Our patient-centered technology has led to over one million treatments provided worldwide using RegenLab® products. In 2017, a new Good Manufacturing Practice (GMP) facility was completed in Mont-sur-Lausanne, Switzerland (canton of Vaud) allowing RegenLab® to increase access to autologous cellular therapies around the world. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine
Your Rating
You must submit at least one review.
Review successfully posted.
You will shortly receive an email to confirm your review.
Currently no review was submitted for this company. Share your experiences with this company!